Neuromodulation Devices Market to Hit USD 9.34 Billion by 2026; Increasing Patient Population Worldwide to Feed Market Expansion: Fortune Business Insights™

NEXT STORY
Vir Biotechnology Proceeding with Two Clinical Development Candidates for COVID-19
PREV STORY
Audited Full Year Results for the year ended 31 December 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atossa Therapeutics Receives Approval from Swedish Regulators to Initiate Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density

author_avatar
NASDAQ Market News

Dynavax Reports Data for Phase 1b/2 Trial of SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Overall Response Rate (ORR) of 70% and 6-month Progression Free Survival (PFS) rate of ...

author_avatar
NASDAQ Market News

Sunesis Pharmaceuticals to Present at the 19th Annual BIO CEO & Investor Conference

SOUTH SAN FRANCISCO, Calif., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

author_avatar
NASDAQ Market News